| Search by tag or site | Login to my blog ? Start my own blog |
 |
BioHealth InvestorBioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network. |
Blogfile: Dendreon Corporation (dndn)
Posted on 05/14/2007 08:57:04 | Link | Post Comment
BioHealth Investor.com
COMPANY BlogFILE
updated: May 13, 2007
DENDREON CORPORATION
3005 First Avenue
Seattle, WA 98121
Phone: (206) 256-4545
Fax: (206) 256-0571
www.dendreon.com
Investor/Public Relations
(206) 829-1500
ir@dendreon.com
COMPANY DESCRIPTION
Dendreon Corporation is a Seattle-based biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.
Through innovative science and technology, is striving to develop and commercialize products that address unmet medical needs, improve survival and have a favorable safety profile.
BUSINESS INFORMATION
Public company
Ticker: DNDN
Market: NASDAQ
Industry: Biotechnology
LATEST BLOG COMMENTARY
Rantasorous Rx
Health Business Blog
May 11, 2007
Comments From Dendreon's Conference Call (May 10, 2007)
24/7 Wall St.
May 10, 2007
Dendreon Gets Complete Response Letter
Eye On FDA
May 09, 2007
Dendreon Nailed by FDA
24/7 Wall St.
May 09, 2007
Dendreon: The Short Story
SeekingAlpha
May 09, 2007
Dendreon: The Next Genentech/Amgen?
SeekingAlpha
May 04, 2007
Source: BioHealth Investor.com
____________________
COMPANY BlogFILE
updated: May 13, 2007
DENDREON CORPORATION
3005 First Avenue
Seattle, WA 98121
Phone: (206) 256-4545
Fax: (206) 256-0571
www.dendreon.com
Investor/Public Relations
(206) 829-1500
ir@dendreon.com
COMPANY DESCRIPTION
Dendreon Corporation is a Seattle-based biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.
Through innovative science and technology, is striving to develop and commercialize products that address unmet medical needs, improve survival and have a favorable safety profile.
BUSINESS INFORMATION
Public company
Ticker: DNDN
Market: NASDAQ
Industry: Biotechnology
LATEST BLOG COMMENTARY
Rantasorous Rx
Health Business Blog
May 11, 2007
Comments From Dendreon's Conference Call (May 10, 2007)
24/7 Wall St.
May 10, 2007
Dendreon Gets Complete Response Letter
Eye On FDA
May 09, 2007
Dendreon Nailed by FDA
24/7 Wall St.
May 09, 2007
Dendreon: The Short Story
SeekingAlpha
May 09, 2007
Dendreon: The Next Genentech/Amgen?
SeekingAlpha
May 04, 2007
Source: BioHealth Investor.com
____________________
- Mri To Lead Growth In Medical-imaging Market
- Malaria And Hiv - Eradication And Treatment
- Dragon’s New Production Process To Cut Costs
- Mrsa Update: Cepheid, Basilea And Nektar
- If Only Us Health Care Could Be More Like The Patriots (or Even The Red Sox) And Less Like The Yankees
- e-techblog
- Wishing Wealth
- Financial Skeptic
- Don't Mess With Taxes
- Millionaire Now! by Larry Nusbaum
- 360 Digest
Examples
Morpheus Trading - Thu Jul 17, 2008 01:15AM
NOTE: Please click on the charts below to enlarge them if th [read more]
NOTE: Please click on the charts below to enlarge them if th [read more]
Morpheus Trading - Mon Jul 21, 2008 08:33AM
NOTE: Please click on the charts below to enlarge them if [read more]
NOTE: Please click on the charts below to enlarge them if [read more]
The Swing of Things - Thu Jul 17, 2008 09:36AM
I used to make a pretty good living sharing hard won [read more]
I used to make a pretty good living sharing hard won [read more]
<< My Home | TheMoneyBlogs Home